opportunity stated: "if it were easy don't you think that someone would have cracked this wide open by now? It will happen."
Opportunity, I don't think it may matter much if it is easy or not. Abbott has a license and they apparently aren't even interested in proceeding. If a company like Abbott is not interested and Alere is no longer even giving progress reports, what reason would a Roche or someone else be interested?
News 
Market Data 
Discover 
